Primary peptide: KPV at 300 to 500 mcg subcutaneously daily (NF-kB suppression in airway epithelium) Support peptide: Ta1 at 1.6 mg subcutaneously twice weekly (immune rebalancing) Duration: 8 to 12 weeks minimum, with reassessment Important note: Peptide protocols for asthma should complement, not replace, prescribed controller medications
Calcitriol intervention significantly restores vitamin D receptor expression, enhances autophagy flux, stimulates mucin/antimicrobial peptide production, and inhibits NF-B-mediated inflammatory responses
[DOI] [PubMed] [Google Scholar] 77.Sikiric P., Seiwerth S., Grabarevic Z., Rucman R., Petek M., Jagic V., Turkovic B., Rotkvic I., Mise S., Zoricic I., et al
The DoD SBIR Schedule How often does the DoD publish new SBIR opportunities